Case Report: Convalescent Plasma Therapy Induced Anti-SARS-CoV-2 T Cell Expansion, NK Cell Maturation and Virus Clearance in a B Cell Deficient Patient After CD19 CAR T Cell Therapy
Here, we described the case of a B cell-deficient patient after CD19 CAR-T cell therapy for refractory B cell Non-Hodgkin Lymphoma with protracted coronavirus disease 2019 (COVID-19). For weeks, this patient only inefficiently contained the virus while convalescent plasma transfusion correlated with...
Main Authors: | Berislav Bošnjak, Ivan Odak, Christiane Ritter, Klaus Stahl, Theresa Graalmann, Lars Steinbrück, Rainer Blasczyk, Christine S. Falk, Thomas F. Schulz, Hans Heinrich Wedemeyer, Markus Cornberg, Arnold Ganser, Reinhold Förster, Christian Koenecke |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-08-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fimmu.2021.721738/full |
Similar Items
-
Reappearance of effector T cells is associated with recovery from COVID-19
by: Ivan Odak, et al.
Published: (2020-07-01) -
Human γδ T Cell Receptor Repertoires in Peripheral Blood Remain Stable Despite Clearance of Persistent Hepatitis C Virus Infection by Direct-Acting Antiviral Drug Therapy
by: Sarina Ravens, et al.
Published: (2018-03-01) -
Complications after CD19+ CAR T-Cell Therapy
by: Olaf Penack, et al.
Published: (2020-11-01) -
Hepatitis E Virus (HEV)-Specific T Cell Receptor Cross-Recognition: Implications for Immunotherapy
by: Chai Fen Soon, et al.
Published: (2019-09-01) -
MicroRNA in T-Cell Development and T-Cell Mediated Acute Graft-Versus-Host Disease
by: Christian Koenecke, et al.
Published: (2018-05-01)